← Back
$MLYS All transactions

Mineralys Therapeutics, Inc.

A

$ Value

$0

Shares

8,300

Price

$0

Filed

Feb 20

Insider

Name

Karydas Daphne

Title

CIK

0001816952

Roles

Director

Transaction Details

Transaction Date

2026-02-19

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

8,300

Footnotes

Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting of these RSUs in one annual installment following the date of grant. | The stock option vests in 12 substantially equal monthly installments following the date of grant.

Filing Info

Accession No.

0001933414-26-000042

Form Type

4

Issuer CIK

0001933414

Karydas Daphne's History

Date Ticker Type Value
2026-03-31 MLYS M $36K
2026-03-31 MLYS $75K
2026-03-31 MLYS M $0
2026-02-19 MLYS A $0
2026-02-19 MLYS A $0
2025-11-13 MLYS M $153K
2025-11-13 MLYS $463K
2025-11-13 MLYS $226K
2025-11-13 MLYS M $0
2025-06-12 CMPS A $0

Other Insiders at MLYS (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $8.8M 2026-03-30
AKKARAJU SRINIVAS 2026-02-19
SBLENDORIO GLENN 2026-02-19
Congleton Jon
Chief Executive Officer
$2.4M 2026-04-13
Rodman David Malcom
Chief Medical Officer
$1.9M 2026-04-17
Levy Adam Scott
CFO and Secretary
2026-02-19
DiRocco Derek 2026-02-19
Karydas Daphne $75K 2026-03-31
Slingsby Brian Taylor 2026-02-19
Gold Alexander M 2026-02-19